Savara Pharmaceuticals
SVRA
#6890
Rank
ยฃ0.36 B
Marketcap
ยฃ2.13
Share price
6.15%
Change (1 day)
-44.17%
Change (1 year)

EPS for Savara Pharmaceuticals (SVRA)

EPS in 2023 (TTM): -ยฃ0.23

According to Savara Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -ยฃ0.22. In 2022 the company made an earnings per share (EPS) of -ยฃ0.19 an increase over its 2021 EPS that were of -ยฃ0.26.

EPS history for Savara Pharmaceuticals from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ0.2320.39%
2022-ยฃ0.19-26.47%
2021-ยฃ0.26-59.52%
2020-ยฃ0.65-56.48%
2019-ยฃ1.492.66%
2018-ยฃ1.45-38.56%
2017-ยฃ2.36-71.06%
2016-ยฃ8.17-37.06%
2015-ยฃ12.984.35%
2014-ยฃ12.44-25.81%
2013-ยฃ16.77-8.82%
2012-ยฃ18.39-27.66%
2011-ยฃ25.42-58.41%
2010-ยฃ61.11-86%
2009-ยฃ436.444.13%
2008-ยฃ419.1424%
2007-ยฃ338.01-35.9%
2006-ยฃ527.3095%
2005-ยฃ270.4153.85%
2004-ยฃ175.7744.44%
2003-ยฃ121.69-40%
2002-ยฃ202.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-ยฃ0.77 257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.21-3.57%๐Ÿ‡บ๐Ÿ‡ธ USA